Study Quantifies Various Types of Sleep Disturbance Prevalent in Rare Disease Population
August 25th 2022New research supports the inclusion of sleep disturbance in clinical evaluation and management in the treatment of Phelan-McDermid Syndrome (PMS) due to the drastic impact it can have on the quality of life for patients and their families.
Read More
Dermatologist Aim to Define Antibiotic Stewardship
August 16th 2022Dermatologists addressed the overprescribing of antibiotics while acknowledging the necessity of antibiotics. Excessive prescribing practices contribute to the emergence of antibiotic resistance and furthers a patient's risk for resistant infections and treatment failures.
Read More
Phase 2 Data Support Continued Evaluation of Mitapivat for Alpha, Beta Thalassemia
August 16th 2022Data from this phase 2 study revealed that the efficacy and safety results support the continued investigation of mitapivat as treatment for adults with either α- or β-thalassemia who are not dependent on transfusions.
Read More
Investigators Highlight Unmet Needs of Patients with Generalized Pustular Psoriasis
August 15th 2022Among flares identified in outpatient (53%), inpatient (36%), and emergency department (9%) settings, the most utilized treatments were topical corticosteroids (35%), opioids (21%), and other oral treatments.
Read More
CDC will Include New ICD-10-CM Diagnosis Code for a Rare Disease in Fall
August 5th 2022In October, a new ICD-10-CM diagnosis code will be activated for APDS, a rare primary immunodeficiency disease, which will enable physicians and payers to add the diagnosis to patient charts for the first time in the US.
Read More
New Guideline on Vaccination Recommendations for Patients with Rheumatic and Musculoskeletal Disease
August 3rd 2022The new treatment guideline addressed the possibility of differing safety and effectiveness outcomes among patients with rheumatic and musculoskeletal disease regarding vaccination compared with the general population.
Read More
Decreased Length of Stay After Total Joint Arthroplasty Predicted by Sleep Quality
July 29th 2022Patients with high preoperative sleep quality, high preoperative albumin level, free of digestive disease and undergoing total hip arthroplasty procedure are more likely to be discharged within 2 days as opposed to 3.
Read More
Study Supports Capsaicin as Potential Pain Treatment for Patients with SCD
July 25th 2022Investigators found that when assessing patients with sickle cell disease and neuropathic pain the TRPV1 receptor is a crucial component in the development of hypersensitivity and potential therapeutic benefit of capsaicin.
Read More